Gaviscon and Bone marrow failure - a phase IV clinical study of FDA data

Summary:

Bone marrow failure is reported as a side effect among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Diabetes.

The phase IV clinical study analyzes which people have Bone marrow failure when taking Gaviscon. It is created by eHealthMe based on reports of 11,990 people who have side effects when taking Gaviscon from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Bone marrow failure?

Bone marrow failure is found to be associated with 1,011 drugs and 1,438 conditions by eHealthMe. Check the latest studies of Bone marrow failure.

On Jul, 26, 2026

11,990 people reported to have side effects when taking Gaviscon.
Among them, 24 people (0.2%) have Bone marrow failure.

Could Gaviscon cause Bone marrow failure?

Among these 24 people:

How long have people been on Gaviscon when they have Bone marrow failure? *

What is the gender of people who have Bone marrow failure when taking Gaviscon? *

female: 52.17 %
male: 47.83 %

What is the age of people who have Bone marrow failure when taking Gaviscon? *

What are other drugs people take besides Gaviscon? *

What are other side effects people have besides Bone marrow failure? *

Fever: 7 people, 29.17%
Nausea And Vomiting: 5 people, 20.83%
Diarrhea: 5 people, 20.83%
Thrombocytopenia (decrease of platelets in blood): 5 people, 20.83%
Wound Infection: 4 people, 16.67%
Fatigue (feeling of tiredness): 4 people, 16.67%
Feeling Abnormal: 4 people, 16.67%
Fluid Retention (an abnormal accumulation of fluid in the blood): 4 people, 16.67%
Hair Loss: 4 people, 16.67%
Heart Rate Increased: 4 people, 16.67%

What are the existing conditions these people have? *

Diabetes: 6 people, 25.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 20.83%
Urinary Tract Infection: 4 people, 16.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 16.67%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 12.50%
Osteoporosis (bones weak and more likely to break): 2 people, 8.33%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 8.33%
High Blood Pressure: 1 person, 4.17%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 4.17%
Bone Sarcoma (bone cancer): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and have Bone marrow failure?

- Check whether Bone marrow failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gaviscon:

Gaviscon (12,355 reports)

Bone marrow failure treatments and more:

Bone marrow failure (25,592 reports)

How severe was Bone marrow failure and when was it recovered:

Bone marrow failure in Gaviscon

Expand to all the drugs that have ingredients of aluminum hydroxide; magnesium trisilicate:

Bone marrow failure and drugs with ingredients of aluminum hydroxide; magnesium trisilicate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone marrow failure:

Bone marrow failure (1,011 drugs)

Browse all the conditions that are associated with Bone marrow failure:

Bone marrow failure (1,438 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aluminum hydroxide; magnesium trisilicate (the active ingredients of Gaviscon) and Gaviscon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.